Literature DB >> 16828857

Acoustic startle response is disrupted in iron-deficient rats.

Erica L Unger1, Laura E Bianco, Maggie S Burhans, Byron C Jones, John L Beard.   

Abstract

Diurnal effects on motor control are evident in the human disease of Restless Leg Syndrome (RLS), which is purported to be linked to brain iron deficiency as well as alterations in dopaminergic systems. Thus, we explored the relationship between daily rhythms, the onset of motor dysregulation and brain iron deficiency in an animal model of iron deficiency. Male and female weanling Sprague-Dawley rats consuming control (CN) or iron-deficient (ID) diets were examined weekly for acoustic startle response (ASR) and prepulse inhibition (PPI) for a 5-week period. Iron deficiency reduced the magnitude, but not timing, of the ASR at specific time points. ASR was elevated 60% at the onset of the dark cycle relative to the median of the light cycle in male CN and ID rats. The respective elevation was 400% and 150% in female CN and ID rats during the first 2 weeks of testing. The diurnal cycle of ASR response was attenuated by 3 weeks of testing in both dietary treatment groups. PPI was not affected by iron deficiency, sex, diurnal cycle or the interaction between these factors. These results thus demonstrate that iron deficiency moderately alters ASR signaling although the inhibitory pathways of ASR do not appear to be affected.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16828857     DOI: 10.1016/j.pbb.2006.06.003

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  8 in total

Review 1.  Iron and mechanisms of emotional behavior.

Authors:  Jonghan Kim; Marianne Wessling-Resnick
Journal:  J Nutr Biochem       Date:  2014-08-02       Impact factor: 6.048

2.  Severe postnatal iron deficiency alters emotional behavior and dopamine levels in the prefrontal cortex of young male rats.

Authors:  Yuan Li; Jonghan Kim; Peter D Buckett; Mark Böhlke; Timothy J Maher; Marianne Wessling-Resnick
Journal:  J Nutr       Date:  2011-10-19       Impact factor: 4.798

3.  Iron and restless legs syndrome: treatment, genetics and pathophysiology.

Authors:  James R Connor; Stephanie M Patton; Konrad Oexle; Richard P Allen
Journal:  Sleep Med       Date:  2016-11-10       Impact factor: 3.492

4.  Variables affecting prepulse inhibition of the startle reflex and the response to antipsychotics in DBA/2NCrl mice.

Authors:  Dorothy G Flood; Maciej Gasior; Michael J Marino
Journal:  Psychopharmacology (Berl)       Date:  2007-08-01       Impact factor: 4.530

5.  Iron deficiency with or without anemia impairs prepulse inhibition of the startle reflex.

Authors:  Marc T Pisansky; Robert J Wickham; Jianjun Su; Stephanie Fretham; Li-Lian Yuan; Mu Sun; Jonathan C Gewirtz; Michael K Georgieff
Journal:  Hippocampus       Date:  2013-07-08       Impact factor: 3.899

6.  Auditory and Lower Limb Tactile Prepulse Inhibition in Primary Restless Legs Syndrome: Clues to Its Pathophysiology.

Authors:  Fidias E Leon-Sarmiento; Elizabeth Peckham; Daniel S Leon-Ariza; William Bara-Jimenez; Mark Hallett
Journal:  J Clin Neurophysiol       Date:  2015-08       Impact factor: 2.177

7.  Providing male rats deficient in iron and n-3 fatty acids with iron and alpha-linolenic acid alone affects brain serotonin and cognition differently from combined provision.

Authors:  Jeannine Baumgartner; Cornelius M Smuts; Michael B Zimmermann
Journal:  Lipids Health Dis       Date:  2014-06-13       Impact factor: 3.876

8.  Comprehensive phenotyping revealed transient startle response reduction and histopathological gadolinium localization to perineuronal nets after gadodiamide administration in rats.

Authors:  Johanna Habermeyer; Janina Boyken; Julia Harrer; Fabio Canneva; Veronika Ratz; Sandra Moceri; Jakob Admard; Nicolas Casadei; Gregor Jost; Tobias Bäuerle; Thomas Frenzel; Christoph Schmitz; Gunnar Schütz; Hubertus Pietsch; Stephan von Hörsten
Journal:  Sci Rep       Date:  2020-12-28       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.